It turns out that where a patient gets a diagnosis of HIV affects how quickly he or she gets treatment for the infection.
Bishoy Faltas, MD
Low-cost interventions can improve compliance with HIV therapy, which is directly linked to viral suppression and reduced transmission to partners.
Primary care clinicians take note: here’s a case for routine screening and treatment of early cryptococcal infection, given its prevalence and sequelae in patients with HIV/AIDS.
Immune reconstitution inflammatory syndrome is seen in some HIV-infected patients soon after initiation of antiretroviral therapy. The syndrome can “unmask” dormant opportunistic infections or aggravate existing infections.
A newly published study examines whether kidney transplant in eligible patients with HIV confers improved survival over renal replacement therapy. Results, here.
Long-term highly-active antiretroviral therapy can be associated with disturbing morphologic and metabolic changes. Nevaripine is added to three HAART regimens in this study to evaluate any mitigating effects.
For patients who remained AIDS-free and untreated 10 years after seroconversion, loss of this status was associated with lower CD4 cell counts and higher HIV RNA load.
Results of a recent study found low BMD was strongly associated with body weight, smoking, and prior advanced HIV disease.
A retrospective chart review among HIV-infected patients treated with ART found use of statin medications associated with a lower risk of cancer.
HIV-infected patients have a 2-fold increased risk for MI vs HIV-negative patients. While many are treated for common risk factors, many of those do not reach clinical targets.